Core Affect

04/27/2024

I offer a therapeutic modality called Ketamine-Assisted Psychotherapy (KAP) in
partnership with an organization called Journey Clinical.
Ketamine-Assisted Psychotherapy (KAP) is a holistic modality in which ketamine is
used as a complement to psychotherapy to help eligible patients experience more
frequent breakthroughs and sustained improvement in symptoms. I take on the
psychotherapy portion of the experience, while Journey Clinical’s medical team
supports you on all medical aspects. This includes determining eligibility, developing a
custom treatment plan, prescribing the medicine and monitoring outcomes. Below is
more information about KAP to help you navigate if it may be a good fit for you.

04/25/2024

Yale scientists explain how ketamine vanquishes depression within hours https://ow.ly/E2T650RfSk6

04/24/2024

Ketamine treatment for depression: a review https://ow.ly/GyNS50RfScr

04/23/2024

Efficacy of ketamine therapy in the treatment of depression https://ow.ly/uo2n50RfShu

04/22/2024

This review aims to provide a brief overview of the different uses of ketamine, with an emphasis on examining ketamine’s rapid antidepressant effects spanning molecular, cellular, and network levels.

Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been studied and used for several new indications, ranging from chronic pain ...

04/20/2024

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? https://ow.ly/r3VK50RfSbc

04/20/2024

Making “bad trips” good: How users of psychedelics narratively transform
challenging trips into valuable experiences https://ow.ly/RATz50RfSg6

04/18/2024

Summary: Ketamine reduces symptoms of depression and suicidal thoughts within four hours of a single treatment, and the effects last for up to two weeks. Additional treatments may prolong the effects, researchers say. https://neurosciencenews.com/ketamine-depression-19836/

04/18/2024

A sample of 1247 completed treatment with sufficient data, 62.8 % reported a 50 % or greater improvement on the PHQ-9, d = 1.61, and 62.9 % on the GAD-7, d = 1.56. Three patient subpopulations emerged, characterized by Improvement (79.3 %), Chronic (11.4 %), and Delayed Improvement (9.3 %) for PHQ-9 and GAD-7. https://ow.ly/5s7N50RfS9E

04/18/2024

Ultimately, a better understanding of the specific mechanisms underlying the effects of psychedelics could allow for a more targeted therapeutic approach. We highlight current challenges for psychedelic research and provide a research agenda to foster insight in the causal-mechanistic pathways underlying the efficacy of psychedelic research and therapy https://www.sciencedirect.com/science/article/pii/S0149763422002822?via%3Dihub

04/17/2024

Emotions are universal

04/17/2024

6
The Tao is called the Great Mother:
empty yet inexhaustible,
it gives birth to infinite worlds.

It is always present within you.
You can use it any way you want.